ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Mammography Controversy Continues: Task Force Alters Web Site To Clarify Recommendation On Mammography

December 4, 2009

Abstracts From AACR Annual Meeting

May 28, 1976

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

NCI CTEP Approved Trials For the Month of January

January 31, 2014

NCI RFP Available.

February 11, 2000